Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease

Nutrition in Clinical Practice

Volumn 29, Issue 2, 2014, Pages 238-245

  Daga, Mradul Kumar ^a   Khan, Naushad Ahmad ^a   Malhotra, Varun ^a   Kumar, Suman ^a   Mawari, Govind ^a   Hira, Harmanjit Singh ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

anabolic agents; chronic obstructive pulmonary disease; nandrolone; nutrition; nutrition assessment

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DECANEURABOL; HEMOGLOBIN; NANDROLONE DECANOATE; OXYGEN; PROTEIN; STEROID; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD OXYGEN TENSION; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PERFORMANCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DOUBLE BLIND PROCEDURE; ENDOCRINE DISEASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HAND GRIP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; LUNG FUNCTION; MALE; MIDDLE AGED; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT RESPONSE; VERY ELDERLY; WALKING;

ANABOLIC AGENTS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; NANDROLONE; NUTRITION; NUTRITION ASSESSMENT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANABOLIC AGENTS; ANTHROPOMETRY; BODY COMPOSITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXERCISE TEST; HUMANS; LUNG; MALE; MIDDLE AGED; NANDROLONE; PHYSICAL FITNESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; WALKING;

EID: 84896342366     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533614522832     Document Type: Article

References (22)

1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 ; 349: 1498-1504
2. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 ; 157: 1791-1797
3. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 ; 160: 1858-1861
4. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease: the National Institute of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis. 1989 ; 139: 1435-1438
5. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 ; 153: 961-966
6. Baarends EM, Schols AMWJ, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients of chronic obstructive pulmonary disease. Eu Respir J. 1997 ; 10: 2807-2813
7. Palange P, Forte S, Felli A, Galasetti P, Serra P, Carlone S. Nutritional state and exercise tolerance in patients with COPD. Chest. 1995 ; 107: 1206-1212
8. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-section is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002 ; 166: 809-813
9. Rogers RM, Donahoe M, Constantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 ; 146: 1511-1517
10. Shridhar MK, Galloway A, Lean MEJ, Banham SW. An out-patient nutritional programme in COPD patients. Eur Respir J. 1994 ; 7: 720-724
11. Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988 ; 92: 181-99
12. Creutzberg EC, Wouters EFM, Mostert R, Pluymers RJ, Schols AMWJ. A role of anabolic steroids in the rehabilitation o patients with COPD. Chest. 2003 ; 124: 1733-1742
13. Casaburi R, Bhasin S, Cosentino L. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respr Crit Care. 2004 ; 170: 1220-1226
14. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998 ; 114: 19-28
15. Yeh SS, DeGuzman B, Kramer T. Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. Chest. 2002 ; 122: 421-428
16. Shin PT, May B, McDowell MS, John AS, Steele RN. A new self administered questionnaire to monitor health related quality of life in patients with COPD. Chest. 1997 ; 112: 614-622
17. Fess EE Clinical Assessment Recommendations. 2 nd ed.Chicago, IL: American Society of Hand Therapists; 1992:41-45. Casanova JS, ed. Chicago, IL: American Society of Hand Therapists ; 1992: 41-45.
18. Jindal SK. A field study on follow up at 10 years of prevalence of COPD and PEFR. Indian J Med Res. 1993 ; 98: 20-26
19. Ray D, Abel R, Selvaraj KG. A 5-yr prospective epidemiological study of chronic obstructive pulmonary disease in rural south India. Indian J Med Res. 1995 ; 101: 238-244
20. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: the six minute walk test in chronic lung disease pateints. Am J Respir Crit Care Med. 1997 ; 155: 1278-1282
21. Sharma S, Arneja A, McLean L, et al. Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron Respir Dis. 2008 ; 5: 169-176
22. Mathew JT, Veena GV, Kurpad AV, Dsouza GA. Nutritional status predicts outcome in patients hospitalized with exacerbation of COPD. Lung India. 2006 ; 23: 143-146